Denali Therapeutics Inc.
DNLI
$20.49
$0.834.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.75% | 4.27% | 1.39% | 0.32% | -12.70% |
| Total Receivables | -5.88% | 0.28% | 35.71% | 0.00% | -10.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.29% | 2.23% | 5.23% | 11.04% | 69.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.40% | 4.19% | 1.58% | 0.68% | -9.75% |
|
|
|||||
| Total Current Assets | 16.40% | 4.19% | 1.58% | 0.68% | -9.75% |
| Net Property, Plant & Equipment | -9.74% | -4.53% | 8.82% | 79.18% | 80.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -58.34% | 12.30% | -61.85% | -54.58% | -39.64% |
| Total Assets | -0.42% | -16.69% | -27.40% | -22.38% | -19.59% |
|
|
|||||
| Total Accounts Payable | 377.42% | -70.10% | -29.70% | -22.19% | -28.65% |
| Total Accrued Expenses | -17.88% | -0.82% | -2.94% | 17.54% | 7.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.45% | -20.67% | 14.26% | 32.36% | 53.41% |
| Total Finance Division Other Current Liabilities | -12.82% | 49.35% | 38.79% | 94.11% | 38.70% |
| Total Other Current Liabilities | -12.82% | 49.35% | 38.79% | 94.11% | 38.70% |
| Total Current Liabilities | 19.90% | -3.77% | 3.51% | 22.17% | 11.26% |
|
|
|||||
| Total Current Liabilities | 19.90% | -3.77% | 3.51% | 22.17% | 11.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.62% | -22.57% | -20.78% | -8.04% | -6.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,092.74% | -- | 2.38% | -- | -- |
| Total Liabilities | 128.66% | -9.28% | -4.50% | 20.49% | 18.34% |
|
|
|||||
| Common Stock & APIC | 11.25% | 10.77% | 4.05% | 4.26% | 4.40% |
| Retained Earnings | -30.38% | -33.30% | -35.02% | -36.37% | -37.27% |
| Treasury Stock & Other | -133.48% | -66.24% | -80.09% | 135.31% | 257.18% |
| Total Common Equity | -17.51% | -17.56% | -29.75% | -25.95% | -22.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.51% | -17.56% | -29.75% | -25.95% | -22.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.51% | -17.56% | -29.75% | -25.95% | -22.86% |
|
|
|||||